Serina Therapeutics focuses on developing innovative therapeutic solutions utilizing its proprietary technologies. The company specializes in the creation of drug delivery systems that enhance the efficacy and safety of existing medications. Their platform is designed to improve the pharmacokinetics and bioavailability of therapeutic agents, which can lead to better patient outcomes. By leveraging advanced formulation techniques, Serina aims to address significant challenges in drug delivery, particularly for complex biologics and small molecules.

In addition to drug delivery, Serina Therapeutics is also engaged in the development of novel therapeutic candidates targeting various diseases. Their research emphasizes the importance of optimizing drug formulations to maximize therapeutic effects while minimizing side effects. The company’s commitment to scientific rigor and innovation positions it to make meaningful contributions to the pharmaceutical landscape, particularly in areas where traditional therapies may fall short.

United States

Serina Therapeutics is a privately held biotechnology company located in Huntsville, Alabama. We have developed a proprietary, clinically-validated polymer technology based on the water-soluble polymer poly(oxazoline). We call it POZ for short.

Please visit our website at www.serinatherapeutics.com and review the exciting work we are doing in vaccines, Parkinson's disease, pain, oncology and cannabinoid science. 

Cancer

Infectious Diseases

Nervous System Diseases

Psychological Diseases

Serina Therapeutics

Parkinson's disease

SER-214

Small Molecule Pharmaceuticals

Post-operative pain management

SER-227

Epilepsy

SER-228

SER-252

Vaccine

POZ-LNPs

Gene Therapy

Vaccines

Alabama

Marijuana/Cannabinoid-Derived Drugs

Therapeutic

Serina Therapeutics

Company Details